Birdwatch Note Rating
2024-11-29 13:28:52 UTC - HELPFUL
Rated by Participant: 1561A885FCA2C413D65A4A2D214B4B55C758B148950EAAE9890526EB07312732
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details